Eloxx Pharmaceuticals, Inc. (ELOX) Financials

ELOX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 8.5 million 16.1 million
Dec. 31, 2025 5.3 million 17.2 million
Sept. 30, 2023 6.0 million 26.1 million
June 30, 2023 6.0 million 24.6 million

ELOX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -5.5 million 46000
Dec. 31, 2025 ? ?
Sept. 30, 2023 -3.5 million 418000
June 30, 2023 -2.1 million 610000

ELOX Net Income

No data available :(

ELOX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 6.4 million - -
Dec. 31, 2025 4.8 million - -
Sept. 30, 2023 4.8 million 2.6 million 318000
June 30, 2023 4.3 million 3.3 million 496000

ELOX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 ?
Dec. 31, 2025 ?
Sept. 30, 2023 2.7 million
June 30, 2023 2.2 million

ELOX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 1.7 million 2.1 million -
Dec. 31, 2025 - - - -
Sept. 30, 2023 - 1.3 million 2.4 million -
June 30, 2023 - 2.3 million 1.8 million -

ELOX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2023 - -
June 30, 2023 - -

ELOX

Price: $12.47

52 week price:
8.20
17.50

Earnings Per Share: -8.88 USD

P/E Ratio: -0.10

Exchange: OEM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 67300

Market Capitalization: 95.2 million

Links: